986 related articles for article (PubMed ID: 29059249)
1. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
Beseler C; Vollmer T; Graner M; Yu X
PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
[TBL] [Abstract][Full Text] [Related]
2. MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro.
Skorstad G; Vandvik B; Vartdal F; Holmøy T
Eur J Neurol; 2009 Oct; 16(10):1124-9. PubMed ID: 19469834
[TBL] [Abstract][Full Text] [Related]
3. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
[TBL] [Abstract][Full Text] [Related]
4. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
5. Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study.
Mancuso R; Franciotta D; Rovaris M; Caputo D; Sala A; Hernis A; Agostini S; Calvo M; Clerici M
Mult Scler; 2014 Dec; 20(14):1900-3. PubMed ID: 24948690
[TBL] [Abstract][Full Text] [Related]
6. Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.
Jarius S; König FB; Metz I; Ruprecht K; Paul F; Brück W; Wildemann B
J Neuroinflammation; 2017 Aug; 14(1):171. PubMed ID: 28851393
[TBL] [Abstract][Full Text] [Related]
7. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
Gurtner KM; Shosha E; Bryant SC; Andreguetto BD; Murray DL; Pittock SJ; Willrich MAV
Clin Chem Lab Med; 2018 Jun; 56(7):1071-1080. PubMed ID: 29455184
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Harrer A; Tumani H; Niendorf S; Lauda F; Geis C; Weishaupt A; Kleinschnitz C; Rauer S; Kuhle J; Stangel M; Weber F; Uhr M; Linnebank M; Wildemann B; Jarius S; Guger M; Ayzenberg I; Chan A; Zettl U; Wiendl H; Pilz G; Hitzl W; Weber JR; Kraus J
Mult Scler; 2013 Aug; 19(9):1209-12. PubMed ID: 23093485
[TBL] [Abstract][Full Text] [Related]
9. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
[TBL] [Abstract][Full Text] [Related]
10. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
[TBL] [Abstract][Full Text] [Related]
11. Oligoclonal bands: An immunological and clinical approach.
Cabrera CM
Adv Clin Chem; 2022; 109():129-163. PubMed ID: 35953125
[TBL] [Abstract][Full Text] [Related]
12. Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.
Farina G; Magliozzi R; Pitteri M; Reynolds R; Rossi S; Gajofatto A; Benedetti MD; Facchiano F; Monaco S; Calabrese M
J Neuroinflammation; 2017 Feb; 14(1):40. PubMed ID: 28222766
[TBL] [Abstract][Full Text] [Related]
13. Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
Stich O; Kluge J; Speck J; Rauer S
Acta Neurol Scand; 2015 Jun; 131(6):381-8. PubMed ID: 25402869
[TBL] [Abstract][Full Text] [Related]
14. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
Wang Z; Kennedy PG; Dupree C; Wang M; Lee C; Pointon T; Langford TD; Graner MW; Yu X
J Neuroimmune Pharmacol; 2021 Sep; 16(3):567-580. PubMed ID: 32808238
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid.
Virtanen JO; Pietiläinen-Nicklén J; Uotila L; Färkkilä M; Vaheri A; Koskiniemi M
J Neuroimmunol; 2011 Aug; 237(1-2):93-7. PubMed ID: 21767883
[TBL] [Abstract][Full Text] [Related]
16. BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.
Puthenparampil M; Federle L; Miante S; Zito A; Toffanin E; Ruggero S; Ermani M; Pravato S; Poggiali D; Perini P; Rinaldi F; Gallo P
J Neuroinflammation; 2017 Jan; 14(1):11. PubMed ID: 28095856
[TBL] [Abstract][Full Text] [Related]
17. Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands.
Altinier S; Puthenparampil M; Zaninotto M; Toffanin E; Ruggero S; Gallo P; Plebani M
Clin Chim Acta; 2019 Sep; 496():117-120. PubMed ID: 31233736
[TBL] [Abstract][Full Text] [Related]
18. The elusive nature of the oligoclonal bands in multiple sclerosis.
Kennedy PGE; George W; Yu X
J Neurol; 2024 Jan; 271(1):116-124. PubMed ID: 37945762
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases.
Franciotta D; Di Stefano AL; Jarius S; Zardini E; Tavazzi E; Ballerini C; Marchioni E; Bergamaschi R; Ceroni M
J Neuroimmunol; 2011 Jan; 230(1-2):160-3. PubMed ID: 21109310
[TBL] [Abstract][Full Text] [Related]
20. Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides.
Graner M; Pointon T; Manton S; Green M; Dennison K; Davis M; Braiotta G; Craft J; Edwards T; Polonsky B; Fringuello A; Vollmer T; Yu X
PLoS One; 2020; 15(2):e0228883. PubMed ID: 32084151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
